Filter posts

Life Sciences Roundtable Event Addressed the Value of Innovation

Yesterday, BIO’s Jeanne Haggerty, Senior Vice President for Federal Government Relations, participated in a roundtable …

Join us for the IP Symposium at the 2016 BIO World Congress!

Ah, San Diego. What is it they say about you? Come for the beaches…. Stay …

NIH Office of Science Policy Unveils New Resources

The NIH Office of Science Policy (OSP) works on a wide range of issues including …

Judd Gregg: Biodefense Funding Is Crucial to National Security

Writing in the Morning Consult, former Senator Judd Gregg explains critical role of federal programs …

What We’ll Be Talking about at the BIO Spring IPCC Conference

It’s time once again for BIO’s Spring IPCC Conference! BIO’s biannual Intellectual Property Counsels Committee …

"II Ca-Be-lly, or Not II Ca-Be-lly?”: Is The Famous Cabilly II Antibody Patent Near Extinction?

Guest post by Konstantin Linnik, Ph.D., Isaac Hubner, Ph.D, and Lana Gladstein, who are attorneys …

#BIOCEO16 Fireside Chat with Senator Chuck Schumer

New York Senator Chuck Schumer joined attendees at the 2016 BIO CEO & Investor Conference …

Tomorrow: From Volume to Value: Designing a Patient-Centered Healthcare System (Webcast)

Tomorrow at the Newseum, The Hill will be hosting a live discussion about the transition …

Know Your IP Strategy: A Necessity for Technology Start-ups

The Licensing Executives Society Foundation invites start-up companies, with investments of less than $200,000, and …

Patently Biotech’s Top Articles of 2015

Intellectual property and patent reform have dominated headlines in 2015. As we close out the …